🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blinded, positive controlled stud...
Status
Completed
Location
Husada Utama Hospital
Start Date
2024-03-20
Trial ID
NCT06131554
This study was designed to evaluate the antibody response to a Menactra® bo...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00777790
This study will be conducted among children in Saudi Arabia who previously ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00539032
Primary Objective: To demonstrate: * the non-inferiority of the seroprote...
Status
Completed
Location
Investigational Site Number 2080001
Start Date
2019-09-12
Trial ID
NCT03890367
The purpose of this study is to provide critical information on the safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-04-08
Trial ID
NCT03636906
Treatments Being Tested
The study investigated safety profile and the antibody responses to an expe...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00771849
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
The purpose of this trial is to describe the safety and antibody response t...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01442675
The aim of this study was to collect further information regarding an incre...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-20
Trial ID
NCT02591290
Treatments Being Tested
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508